Related Experiment Video
Updated: Sep 11, 2025
Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018
Microdroplet Digital Polymerase Chain Reaction for Precision Detection of Non-Small Cell Lung Cancer Mutations
Youming Lei1, Guoli Lv1, Qingmei Yang1
1The 2nd Department of Thoracic Surgery, First Affiliated Hospital of Kunming Medical University.
Abstract:
On a global scale, lung cancer continues to be the primary contributor to cancer-related deaths, with its prevalence ranking second only to that of kidney cancer. Non-small cell lung cancer (NSCLC) constitutes approximately 80-85% of all reported lung cancer cases. The T790M mutation in the EGFR gene is a widely recognized primary determinant of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The presence of this condition has been observed in approximately 50-60% of those experiencing progressive illness. Therefore, the implementation of an expeditious and highly responsive approach for detecting T790M mutations in the EGFR gene is essential for the expeditious identification of non-small cell lung cancer. In the current study, ddPCR was used to detect the T790M mutation with a detection limit of 10 copies/µL, which is 10-fold higher than the sensitivity of qPCR (1 × 102 copies/µL). For the 15 simulated samples, ddPCR was capable of detecting the presence of T790M mutations in the EGFR gene, which were observed to be at reduced levels when analyzed using qPCR. The detection of T790M mutations inside the EGFR gene by a fast detection method is being investigated to determine its suitability.
Insights
Digital droplet PCR (ddPCR) offers a highly sensitive method for detecting T790M mutations in the EGFR gene, crucial for identifying non-small cell lung cancer (NSCLC) and guiding treatment resistance strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer mortality globally, with non-small cell lung cancer (NSCLC) comprising the majority of cases.
- The T790M mutation in the epidermal growth factor receptor (EGFR) gene is a key factor in acquired resistance to EGFR tyrosine kinase inhibitors (TKIs), affecting 50-60% of patients with progressive disease.
- Rapid and accurate detection of T790M mutations is essential for timely clinical management of NSCLC patients.
Purpose of the Study:
- To evaluate the efficacy of digital droplet PCR (ddPCR) for detecting the T790M mutation in the EGFR gene.
- To compare the sensitivity of ddPCR with quantitative PCR (qPCR) for T790M mutation detection.
- To assess the suitability of a rapid detection method for T790M mutations in NSCLC.
Main Methods:
- Utilized digital droplet PCR (ddPCR) for the detection of T790M mutations in the EGFR gene.
- Compared ddPCR sensitivity (detection limit of 10 copies/µL) against qPCR sensitivity (1 × 10^2 copies/µL).
- Analyzed 15 simulated patient samples to assess mutation detection capabilities.
Main Results:
- ddPCR demonstrated a significantly higher sensitivity in detecting T790M mutations compared to qPCR.
- ddPCR successfully identified T790M mutations in simulated samples where qPCR showed reduced or undetectable levels.
- The detection limit of ddPCR was 10-fold greater than that of qPCR.
Conclusions:
- ddPCR is a highly sensitive and effective method for detecting T790M mutations in the EGFR gene.
- This advanced detection method facilitates the early identification of resistance mechanisms in NSCLC patients.
- The findings support the clinical utility of ddPCR for guiding EGFR-TKI therapy selection and management in NSCLC.
